Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06287346 · ClinicalTrials.gov registry record
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
A clinical trial of Tooth Loss and Edentulism, sponsored by CeraRoot SL.
- Recruiting
- Registry status
- 652
- Enrollment target
- 2
- Study locations
NCT06287346: Recruiting study of Tooth Loss and Edentulism, sponsored by CeraRoot SL.
NCT06287346 is a study of Tooth Loss and Edentulism that is actively recruiting participants, run by CeraRoot SL. The registered enrollment target is 652 participants, above the 45-participant average among 11 other Tooth Loss trials with a reported enrollment target (1349% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06287346, a study of Tooth Loss and Edentulism, is actively recruiting participants, sponsored by CeraRoot SL.
- RECRUITING
- Registry status
- 652 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this cohort observational study is to compare in the survival rate of ceramic dental implants placed in patients with missing or hopeless teeth . The main question\[s\] it aims to answer are: * Are there any significant differences in survival rate between the use of one-piece ceramic implant versus the two-piece (TL) variant? * What are the complications associated to the procedure and differences between the two groups.
Primary Outcome
The implant is osseointegrated and in function in the patient's jaw without pain and no mobility.
Conditions Studied
Interventions
- DEVICE dental implant
Study Locations (2)
Colorado
- Family Holistic Dentistry - Boulder
Barcelona
- CeraRoot CLINIC - Les Franqueses del Vallès
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 652 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2030-01-01 |
What NCT06287346 shows while recruiting
NCT06287346 is an observational study that tracks outcomes without assigning an intervention. The registered 652 participants enrollment target is mid-sized for trials with a published cap, above the 45-participant average among 11 other Tooth Loss trials with a reported enrollment target (1349% higher).
The record links to 2 conditions, with Tooth Loss appearing as the primary indexed condition, and to 1 intervention - of which dental implant is the first listed.
NCT06287346 reports a single indexed study location in Colorado, Barcelona.
Frequently Asked Questions
What is clinical trial NCT06287346 about?
NCT06287346 is a clinical study titled "5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.". The goal of this cohort observational study is to compare in the survival rate of ceramic dental implants placed in patients with missing or hopeless teeth . The main question\[s\] it aims to answer are: * Are there any significant differences in survival rate between the use of one-piece ceramic i...
What is the current status of trial NCT06287346?
This trial is currently recruiting. The enrollment target is 652 participants. The study started on 2024-01-01. Estimated completion is 2030-01-01.
What conditions does trial NCT06287346 study?
This clinical trial studies the following conditions: Tooth Loss, Edentulism.
What interventions are being tested in trial NCT06287346?
The interventions under investigation include: dental implant (DEVICE).
Who is sponsoring clinical trial NCT06287346?
This trial is sponsored by CeraRoot SL, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06287346 being conducted?
This trial has 2 study locations across Colorado, Barcelona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tooth Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06287346's enrollment target sits among peer trials
652 1st of 11 higher than 11 of 11 other Tooth Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tooth Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Peri-implant Mucosal Changes Over Time Following Implant Provisional Removal in the Esthetic Zone
RECRUITING
-
An Observational Study of the T3 Pro Dental Implant System
RECRUITING
-
Clinical Performance of Nobel N1 System
RECRUITING · Phase 4
-
A Clinical Study of the TSX Dental Implant System (Xpresso)
RECRUITING
-
Bone Level Tapered Multi-Center Study
ACTIVE NOT RECRUITING · NA
-
Comparison of Dimensional Changes After Tooth Extractions Between Xenograft and Allograft
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI